Omisa Inc. (Segasist Technologies)
CanadaFDA applicant, unverified
- Devices
- 1
What Omisa Inc. (Segasist Technologies) makes
Omisa Inc. manufactures the Segasist Technologies Segmentation Assistant for Prostate-Auto Contouring, a device designed to assist in automated contouring of the prostate during medical imaging for diagnostic or treatment planning purposes.
The Segmentation Assistant for Prostate-Auto Contouring is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Omisa Inc. (Segasist Technologies) have in the registry?
The registry currently lists 1 device for Omisa Inc. (Segasist Technologies). Devices recorded under merged duplicate company entries are counted once.
Which registries list Omisa Inc. (Segasist Technologies)'s devices?
Among its 1 most recently registered device, Omisa Inc. (Segasist Technologies) has devices listed in FDA 510(k) (1 device).
What risk classes do Omisa Inc. (Segasist Technologies)'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Omisa Inc. (Segasist Technologies)'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Omisa Inc. (Segasist Technologies) in the registry?
The most recently registered devices listed for Omisa Inc. (Segasist Technologies) include SEGMENTATION ASSISTANT FOR PROSTATE-AUTO CONTOURING.